GLP-1 drugs (Ozempic, Mounjaro, Trulicity) are popular treatments for diabetes type 2, weight loss Trulicity, Mounjaro, and Ozempic are all part of a class of medications called glucagon-like peptide-1 (GLP-1) and dual GLP-1/GIP (glucose-dependent insulintropic polypeptide) receptor agonists, which are used to type 2 diabetes and, with respect to certain drugs, for chronic weight management
In addition, there are potential applications in the treatment of some diseases, such as in cancer cachexia patients, which may improve weight loss and loss of appetite, and enhance the quality of life of patients
What happens if I forget to change my patch
Oral medicine interactions: As noted above, delayed gastric emptying a class effect of incretin-based therapies may affect the absorption of certain oral medicines